Tesaro, Inc. (TSRO)

Oncology Corporate Profile

Stock Performance

42.0800
-1.2800

3 Month Stock History Chart

HQ Location

1000 Winter Street, Suite 3300
Waltham, MA 2451

Company Description

Tesar, Inc. is an oncology-focused biopharmaceutical company dedicated to improving the lives of patients with cancer. Our team of passionate associates develops and will commercialize safer and more effective supportive care agents and therapeutics.

Website: http://www.tesarobio.com

Brand Generic Indication
Varubi®rolapitantVarubi® is a substance P/neurokinin 1 (NK1) receptor antagonist indicated in combination with other antiemetic agents in adults for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy, including, but not limited to, highly emetogenic chemotherapy.
Zejula®niraparibZejula® is a poly (ADP ribose) polymerase (PARP) inhibitor indicated for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy.
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
niraparibPARP inhibitorBreast cancerIII
niraparib (+pembrolizumab)PARP inhibitorOvarian cancerII
niraparib (+bevacizumab)PARP inhibitorOvarian cancerII
niraparib (+pembrolizumab)PARP inhibitorTriple negative Breast cancerII
niraparib (+ chemotherapy)PARP inhibitorEwing's SarcomaI
TSR-042anti-PD-1 monoclonal antibodyVarious cancer typesI
TSR-022anti-TIM-3 monoclonal antibodyVarious cancer typesPreclinical

Source: http://www.tesarobio.com

Recent News Headlines

8/21/2017 06:23 am

8/21/2017 06:23 am

8/21/2017 06:23 am

8/21/2017 06:23 am

8/18/2017 12:20 pm

8/18/2017 12:20 pm

8/18/2017 12:20 pm

8/18/2017 12:20 pm

8/18/2017 06:20 am

8/18/2017 06:20 am

8/18/2017 06:20 am

8/16/2017 06:20 am

8/14/2017 06:20 pm

8/14/2017 06:20 pm

8/13/2017 06:20 pm

8/13/2017 06:20 pm

8/13/2017 06:20 pm

8/13/2017 06:20 pm

8/9/2017 06:20 am

8/9/2017 12:20 am

8/9/2017 12:20 am

8/8/2017 12:19 pm

8/8/2017 06:19 am

8/4/2017 06:20 am

8/4/2017 06:20 am